Melville, NYCIK 16016921 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
34 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Angiodynamics Inc | 1.71M | $22.00M | 16.3% | +1.71M | New Position |
| 2 | Aurinia Pharmaceuticals Inc | 1.22M | $19.54M | 14.4% | +1.22M | New Position |
| 3 | Avadel Pharmaceuticals PLC | 741.3K | $15.98M | 11.8% | +741.3K | New Position |
| 4 |
| Omeros Corp |
| 905.6K |
| $15.55M |
| 11.5% |
| +905.6K |
| New Position |
| 5 | Neuropace Inc | 631.5K | $9.75M | 7.2% | +631.5K | New Position |
| 6 | Mediwound Ltd | 337.2K | $6.23M | 4.6% | +337.2K | New Position |
| 7 | Axogen Inc | 168.0K | $5.50M | 4.1% | +168.0K | New Position |
| 8 | Integra Lifesciences Hldgs C | 427.4K | $5.31M | 3.9% | +427.4K | New Position |
| 9 | Aclaris Therapeutics Inc | 1.71M | $5.13M | 3.8% | +1.71M | New Position |
| 10 | Vertical Aerospace Ltd | 939.7K | $5.01M | 3.7% | +939.7K | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio